About the job
Company Overview:
Compass Pathways plc (Nasdaq: CMPS) is a pioneering biotechnology firm headquartered in London, UK, with a significant presence in New York City, USA. Our mission is to expedite patient access to revolutionary, evidence-based solutions for mental health challenges. We are dedicated to creating innovative treatments to improve the lives of individuals suffering from mental health disorders who have not found relief through existing therapies.
We are at the forefront of reshaping mental health treatment paradigms, focusing on rapid and lasting responses through our investigational COMP360 synthetic psilocybin treatment, which is poised to be a groundbreaking therapy. COMP360 has received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) and has also been granted Innovative Licensing and Access Pathway (ILAP) status in the UK for treating treatment-resistant depression (TRD), addressing a critical unmet need in this sector.
Currently, we are advancing through phase 3 trials for TRD, have completed phase 2 studies for post-traumatic stress disorder (PTSD) and anorexia nervosa, and are preparing for additional late-stage studies in PTSD. We aspire to create a world where mental health signifies not just the absence of illness but the capacity to thrive.
Position Overview:
As a Senior Financial Analyst, Commercial, you will provide essential financial planning and analysis (FP&A) support to Commercial OPEX budget stakeholders. This role includes overseeing budgeting processes, quarterly forecasts, long-range strategic planning, and detailed budget versus actual analyses at various levels (department, account, and purchase order). You will be responsible for constructing and maintaining OPEX forecast models related to hub/patient services, travel and expense, and headcount, while collaborating on business cases, purchase order approvals, spend opportunities and risks, SOX compliance, and alignment with accounting practices.

